Literature DB >> 19646990

Renal studies provide an insight into cardiac extracellular matrix remodeling during health and disease.

Alexandre Hertig1, Taduri Gangadhar, Raghu Kalluri.   

Abstract

The remodeling of a heart ventricle after myocardial infarction involves numerous inflammatory mediators that may trigger a long-lasting and a highly fibrogenic process. Likewise, in the kidney, acute and chronic injuries may lead to abnormal extracellular matrix deposition and eventually lead to the loss of renal function. Major breakthroughs have emerged during the last ten years with respect to the pathophysiology of matrix remodeling. Epithelial and endothelial cells are plastic, and able to engage in epithelial (or endothelial)-to-mesenchymal transition (EMT or EndMT), thus actively contributing to the fibrogenesis. Members of the fibrinolytic system were demonstrated to possess unsuspected properties and interact with receptors and integrins on endothelial and epithelial cells. Finally, a notion that stem cells could integrate into damaged tissue has recently emerged, which likely contributes to the tissue repair. In many aspects, the kidney and the heart share many common injury mechanisms. We envision that some of them will be accessible as common therapeutic targets in the future. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19646990      PMCID: PMC4457469          DOI: 10.1016/j.yjmcc.2009.07.022

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  50 in total

1.  Global gene expression analysis reveals a role for the alpha 1 integrin in renal pathogenesis.

Authors:  N S Sampson; S T Ryan; D A Enke; D Cosgrove; V Koteliansky; P Gotwals
Journal:  J Biol Chem       Date:  2001-07-10       Impact factor: 5.157

2.  Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse.

Authors:  Kyungmin Hahm; Matvey E Lukashev; Yi Luo; William J Yang; Brian M Dolinski; Paul H Weinreb; Kenneth J Simon; Li Chun Wang; Diane R Leone; Roy R Lobb; Donald J McCrann; Normand E Allaire; Gerald S Horan; Agnes Fogo; Raghu Kalluri; Charles F Shield; Dean Sheppard; Humphrey A Gardner; Shelia M Violette
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 3.  Acute renal failure.

Authors:  R Thadhani; M Pascual; J V Bonventre
Journal:  N Engl J Med       Date:  1996-05-30       Impact factor: 91.245

4.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

Review 5.  Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease.

Authors:  R A Preston; M Epstein
Journal:  J Hypertens       Date:  1997-12       Impact factor: 4.844

6.  Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling.

Authors:  Kebin Hu; Chuanyue Wu; Wendy M Mars; Youhua Liu
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.

Authors:  Debra F Higgins; Kuniko Kimura; Wanja M Bernhardt; Nikita Shrimanker; Yasuhiro Akai; Bernd Hohenstein; Yoshihiko Saito; Randall S Johnson; Matthias Kretzler; Clemens D Cohen; Kai-Uwe Eckardt; Masayuki Iwano; Volker H Haase
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

8.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.

Authors:  Elisabeth M Zeisberg; Oleg Tarnavski; Michael Zeisberg; Adam L Dorfman; Julie R McMullen; Erika Gustafsson; Anil Chandraker; Xueli Yuan; William T Pu; Anita B Roberts; Eric G Neilson; Mohamed H Sayegh; Seigo Izumo; Raghu Kalluri
Journal:  Nat Med       Date:  2007-07-29       Impact factor: 53.440

Review 9.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

10.  Anatomic demarcation by positional variation in fibroblast gene expression programs.

Authors:  John L Rinn; Chanda Bondre; Hayes B Gladstone; Patrick O Brown; Howard Y Chang
Journal:  PLoS Genet       Date:  2006-07       Impact factor: 5.917

View more
  7 in total

1.  Oxidative stress mediates the conversion of endothelial cells into myofibroblasts via a TGF-β1 and TGF-β2-dependent pathway.

Authors:  Ignacio Montorfano; Alvaro Becerra; Roberto Cerro; César Echeverría; Elizabeth Sáez; María Gabriela Morales; Ricardo Fernández; Claudio Cabello-Verrugio; Felipe Simon
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

Review 2.  Extracellular matrix roles during cardiac repair.

Authors:  Claude Jourdan-Lesaux; Jianhua Zhang; Merry L Lindsey
Journal:  Life Sci       Date:  2010-07-27       Impact factor: 5.037

Review 3.  The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder.

Authors:  Michael E Seifert; Keith A Hruska
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

Review 4.  Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases.

Authors:  Hong Zhao; Yanting Dong; Xinrui Tian; Thian Kui Tan; Zhuola Liu; Ye Zhao; Yun Zhang; David Ch Harris; Guoping Zheng
Journal:  World J Nephrol       Date:  2013-08-06

5.  Understanding the role of the extracellular matrix in cardiovascular development and disease: where do we go from here?

Authors:  Merry L Lindsey; Thomas K Borg
Journal:  J Mol Cell Cardiol       Date:  2009-09-23       Impact factor: 5.000

6.  Finding ATF4/p75NTR/IL-8 signal pathway in endothelial-mesenchymal transition by safrole oxide.

Authors:  Di Ge; Qingchuan Jing; Wenbo Zhao; Hongwei Yue; Le Su; ShangLi Zhang; Jing Zhao
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

7.  Acetyltransferase p300 inhibitor reverses hypertension-induced cardiac fibrosis.

Authors:  Rahul Rai; Tianjiao Sun; Veronica Ramirez; Elizabeth Lux; Mesut Eren; Douglas E Vaughan; Asish K Ghosh
Journal:  J Cell Mol Med       Date:  2019-02-01       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.